SMi are delighted to have Pamela Tranter, Head of Translational Research Group, UCL Chair the inaugural conference this October and also present the opportunities and challenges of
Being the most talked about department within R&D, Cell & Gene Therapy will explore the latest advancements of advanced therapy medicinal products (ATMPs) by discussing, the challenges of a
While cancer continues to be one of the leading causes of death and illness, new technology and increasing use of real-world data have the potential to revolutionise care.
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio